Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FTC HGH case

This article was originally published in The Tan Sheet

Executive Summary

Pacific Herbal Sciences, Natural Health Product, New Star Marketing Group and their presidents are named in as defendants by FTC in a complaint stating their oral spray products do not contain Human Growth Hormone (HGH) or cause the body to produce it. The complaint also charges that false and deceptive claims for Natural Rejuvenator HGH-R and HGH Revolution state the products cause consumers to "lose weight while you sleep without dieting or exercise" and "experience up to an 82% improvement in body fat loss while erasing 10 years in 10 weeks." FTC is seeking a permanent ban on the false claims and illegal spam, as well as money for consumer redress...

You may also be interested in...



“Egregiously False” HGH Claims Get Marketers In Hot Water At FTC

Two California businessmen cited for making "egregiously false" claims for human growth hormone-containing products have agreed to settlements shutting down their operations, the Federal Trade Commission said May 29

UK Set For January Brexit After Conservatives Win Election

The Conservative Party's victory in the UK general election means the Brexit withdrawal deal will be able to pass. The UK will leave the EU by 31 January and enter a transition period during which medicines regulation will remain broadly unchanged.

Dainippon, SanBio Call Time On Stroke Cell Therapy Alliance

Japanese companies agree to discontinue regenerative cell therapy pact after high-profile Phase II failure, but SanBio will move ahead with development and Dainippon will hold onto ex-partner stake for now.

Topics

UsernamePublicRestriction

Register

PS098756

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel